284 related articles for article (PubMed ID: 36330477)
1. Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through
Ghatak S; Hascall VC; Karamanos N; Markwald RR; Misra S
Front Oncol; 2022; 12():906260. PubMed ID: 36330477
[TBL] [Abstract][Full Text] [Related]
2. Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance.
Ghatak S; Hascall VC; Karamanos N; Markwald RR; Misra S
Front Oncol; 2022; 12():906415. PubMed ID: 35982950
[TBL] [Abstract][Full Text] [Related]
3. FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells.
Ghatak S; Hascall VC; Markwald RR; Misra S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451103
[TBL] [Abstract][Full Text] [Related]
4. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
6. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
Kang DW; Min do S
PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
[TBL] [Abstract][Full Text] [Related]
7. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
[TBL] [Abstract][Full Text] [Related]
8. The beta-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression.
Gonçalves V; Matos P; Jordan P
RNA; 2008 Dec; 14(12):2538-49. PubMed ID: 18952824
[TBL] [Abstract][Full Text] [Related]
9. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
[TBL] [Abstract][Full Text] [Related]
10. Disabled-2 (Dab2) inhibits Wnt/β-catenin signalling by binding LRP6 and promoting its internalization through clathrin.
Jiang Y; He X; Howe PH
EMBO J; 2012 May; 31(10):2336-49. PubMed ID: 22491013
[TBL] [Abstract][Full Text] [Related]
11. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
12. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
[TBL] [Abstract][Full Text] [Related]
13. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
14. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling.
Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z
J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424
[TBL] [Abstract][Full Text] [Related]
15. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
[TBL] [Abstract][Full Text] [Related]
16. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
[TBL] [Abstract][Full Text] [Related]
18. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
[TBL] [Abstract][Full Text] [Related]
19. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
[TBL] [Abstract][Full Text] [Related]
20. Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling.
Lei ZJ; Wang J; Xiao HL; Guo Y; Wang T; Li Q; Liu L; Luo X; Fan LL; Lin L; Mao CY; Wang SN; Wei YL; Lan CH; Jiang J; Yang XJ; Liu PD; Chen DF; Wang B
Oncogene; 2015 Jun; 34(24):3188-98. PubMed ID: 25893304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]